Prognozy (mln)
| Okres | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | 2029-12-31 |
| Przychód (średnia) | 1,912.82 | 1,921.32 | 2,281.35 | 3,097.61 | 5,595.80 |
| Przychód Δ r/r | 0.00% | 0.44% | 18.74% | 35.78% | 80.65% |
| Przychód (min) | 1,843.08 | 1,422.16 | 2,261.38 | 2,576.20 | 4,653.89 |
| Przychód (max) | 2,092.15 | 2,203.87 | 2,301.32 | 3,546.03 | 6,405.87 |
| EBITDA (średnia) | -411.13 | -412.95 | -490.34 | -665.78 | -1,202.72 |
| EBIT (średnia) | -472.76 | -474.86 | -563.84 | -765.58 | -1,383.02 |
| EBIT % | -24.72% | -24.72% | -24.72% | -24.72% | -24.72% |
| Zysk netto % | -162.52% | -147.17% | -84.44% | -38.35% | -0.65% |
| EPS (średnia) | -8.10 | -6.81 | -4.60 | -3.09 | -0.09 |
| Liczba analityków (Przychody) | 14 | 16 | 16 | 14 | 15 |
| Liczba analityków (EPS) | 13 | 14 | 12 | 7 | 10 |
| symbol | MRNA | MRNA | MRNA | MRNA | MRNA |